Modulation of hypoxia in murine liver metastases of colon carcinoma by nicotinamide and carbogen

Radiation Research

Volumn 164, Issue 3, 2005, Pages 245-249

  Van Laarhoven, H W M ^a   Bussink, J ^a   Lok, J ^a   Verhagen, I ^a   Punt, C J A ^a   Heerschap, A ^a   Kaanders, J H A M ^a   Van Der Kogel, A J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOGEN; NICOTINAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HYPOXIA; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR BLOOD FLOW;

ANIMALS; CARBON DIOXIDE; CARCINOMA; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DRUG COMBINATIONS; FEMALE; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; NIACINAMIDE; OXYGEN;

MURINAE;

EID: 24144456236     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3435.1     Document Type: Article

References (27)

1. J. M. Brown, Exploiting the hypoxic cancer cell: Mechanisms and therapeutic strategies. Mol. Med. Today 6, 157-162 (2000).
2. J. H. Kaanders, J. Bussink and A. J. van der Kogel, Clinical studies of hypoxia modification in radiotherapy. Semin. Radiat. Oncol. 14, 233-240 (2004).
3. W. L. Monsky, C. C. Mouta, Y. Tsuzuki, T. Gohongi, D. Fukumura and R. K. Jain, Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. Clin. Cancer Res. 8, 1008-1013 (2002).
4. H. W. van Laarhoven, J. Bussink, J. Lok, C. J. Punt, A. Heerschap and A. J. van der Kogel, Effects of nicotinamide and carbogen in different murine colon carcinomas: Immunohistochemical analysis of vascular architecture and microenvironmental parameters. Int. J. Radiat. Oncol. Biol. Phys. 60, 310-321 (2004).
5. R. E. Durand and J. A. Raleigh. Identification of nonproliferating but viable hypoxic tumor cells in vivo. Cancer Rex. 58, 3547-3550 (1998).
6. G. E. Arteel, R. G. Thurman, J. M. Yates and J. A. Raleigh, Evidence that hypoxia markers detect oxygen gradients in liver: Pimonidazole and retrograde perfusion of rat liver. Br. J. Cancer 12, 889-895 (1995).
7. J. A. Raleigh, S. C. Chou, G. E. Arteel and M. R. Horsman, Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat. Res. 151, 580-589 (1999).
8. J. Bussink, J. H. Kaanders, A. M. Strik and A. J. van der Kogel, Effects of nicotinamide and carbogen on oxygenation in human tumor xenografts measured with luminescence based fiber-optic probes. Radiother. Oncol. 57, 21-30 (2000).
9. B. P. van der Sanden, B. P. Heerschap, A. Hoofd, L. Simonetti, K. Nicolay, K. van der Toom, W. N. Colier and A. J. van der Kogel, Effect of carbogen breathing on the physiological profile of human glioma xenografts. Magn. Reson. Med. 42, 490-499 (1999).
10. J. R. Westphal, R. G. van't Hullenaar, J. A. van der Laak, I. M. Cornelissen, L. J. Schalkwijk, G. N. van Muijen, P. Wesseling, P. C. de Wilde, D. J. Ruiter and R. M. de Waal, Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential. Br. J. Cancer 76, 561-570 (1997).
11. P. F. Rijken, H. J. Bernsen and A. J. van der Kogel, Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. Microvasc. Rex. 50, 141-153 (1995).
12. J. Bussink, J. H. Kaanders, P. F. Rijken, C. A. Martindale and A. J. van der Kogel, Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts. Br. J. Cancer 77, 57-64 (1998).
13. J. Bussink, J. H. Kaanders, P. F. Rijken, J. A. Raleigh and A. J. van der Kogel, Changes in blood perfusion and hypoxia after irradiation of a human squamous cell carcinoma xenograft tumor line. Radiat. Res. 153, 398-404 (2000).
14. P. B. Vermeulen, C. Colpaert, R. Salgado, R. Royers, H. Hellemans, H. E. Van Den, G. Goovaerts, L. Y. Dirix and E. van Marck, Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J. Pathol. 195, 336-342 (2001).
15. D. J. Chaplin, M. R. Horsman and M. J. Trotter, Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor. J. Natl. Cancer Inst. 82, 672-676 (1990).
16. S. A. Hill and D. J. Chaplin, The effect of nicotinamide on microregional blood flow within tumours assessed using laser Doppler probes. Acta Oncol. 34, 401-404 (1995).
17. H. P. Ammon and C. J. Estler, The effect of nicotinic acid on glycolytic carbohydrate breakdown in the liver. Life Sci. 6, 641-647 (1967).
18. F. J. Moreno, L. Sanchez-Urrutia, J. M. Medina, F. Sanchez-Medina and F. Mayor, Stimulation of phosphoenolpyruvate carboxykinase (guanosine triphosphate) activity by low concentrations of circulating glucose in perfused rat liver. Biochem. J. 150, 51-58 (1975).
19. H. G. Crabtree, Observations on the carbohydrate metabolism of tumours. Biochem. J. 23, 536-545 (1929).
20. M. E. Powell, S. A. Hill, M. I. Saunders, P. J. Hoskin and D. J. Chaplin. Effect of carbogen breathing on tumour microregional blood flow in humans. Radiother. Oncol. 41, 225-231 (1996).
21. R. L. Jirtle. Chemical modification of tumour blood flow. Int. J. Hyperthermia 4, 355-371 (1988).
22. P. Vaupel, A. Mayer and M. Hockel, Tumor hypoxia and malignant progression. Methods Enzymol. 381, 335-354 (2004).
23. J. H. Kaanders, L. A. Pop, H. A. Marres, J. Liefers, F. J. van den Hoogen, W. A. van Daal and A. J. van der Kogel, Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer. Radiother. Oncol. 48, 115-122 (1998).
24. P. J. Hoskin, M. I. Saunders, H. Phillips, H. Cladd, M. E. Powell, K. Goodchild, M. R. Stratford and A. Rojas, Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy. Br. J. Cancer 76, 260-263 (1997).
25. M. J. Droller, Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: Hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen and nicotinamide. J. Urol. 163, 1600 (2000).
26. K. Pigott, S. Dische and M. I. Saunders, Short communication: The addition of carbogen and nicotinamide to a palliative fractionation schedule for locally advanced breast cancer. Br. J. Radiol. 68, 215-218 (1995).
27. L. Harrison and K. Blackwell, Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist 9 (Suppl.). 31-40 (2004).